Anuja Java, MD (she/her)

Txp Neph @WUNephrology Dir. Kidney Txp @stlouisva co-chair KDWG @clingenresource. AE @KidneyMed. Rsrch #complement #genetics #TMA #AMD #Preeclampsia RT#endorse

[Anuja Java, MD (she/her) @anuja_java]

Was thrilled to receive this letter about one of my transplant pts who made a donation to the hospital in my name.

As physicians, the trust & well-being of our pts matters most!!

This beautiful gesture tells me I am doing it right. Feeling blessed & happy😊 @WUNephrology⁩

[American Society of Onconephrology @onconephsociety]

📍 Happening now at @ASNKidney KidneyWeek in Denver!

Join us for the ASN OncoNephrology Program for a day of cutting-edge science, emerging cancer therapies, and practical insights.
Are your ready? 🫘

@onconeph @rc_oncneph @SheronLatcha @ShrutiGkidney @PaulHannaMD @hhashmi87

[WashU Nephrology @WashUNephrology]

Don’t miss @anuja_java's presentation and panel at #KidneyWk 2026 Early Program!
Explore the full @WashUNephrology calendar: https://t.co/A99V46CVGk

[WashU Nephrology @WashUNephrology]

Denver, here we come! Check out our 2026 ASN #KidneyWk @WashUNephrology calendar of presentations, posters, and more!
https://t.co/A99V46DtvS

[American Society of Onconephrology @onconephsociety]

How much kidney function is enough for the right dose?

This session by @PaulHannaMD and Thomas Nolin looks at individualising GFR assessment and multidisciplinary dose adjustment of anticancer therapies in CKD and ESKD.

@rc_oncneph @onconeph @SheronLatcha @ShrutiGkidney

[American Society of Onconephrology @onconephsociety]

🩸Thrombotic Microangiopathy in Patients with Cancer 🩸

Cancer associated TMA can be complex, especially when complement activation is involved.

This session by @anuja_java will explore the role of complement regulation and inhibition in these patients.

@rc_oncneph @onconeph

[American Society of Onconephrology @onconephsociety]

Our next session?

🩺Case Based Debates in Onconephrology ➡️ To Transplant or Not to Transplant in patients with cancers ?

Discussants : Nadia Al Haddad, @hhashmi87 @anuja_java @nymurakami @itunuowoyemi

Register 🔗: https://t.co/aGTcge4zaS

@rc_oncneph @onconeph @SheronLatcha

[American Society of Onconephrology @onconephsociety]

🦀🫘👩🏻‍⚕️Kidney Transplant Onconephrology

How do we approach cancer treatment in KTRs?

Dr Murakami @nymurakami discusses immunotherapy, engineered cellular therapies and management of PTLDs

Register 🔗 : https://t.co/aGTcge4zaS

@onconeph @SheronLatcha @rc_oncneph @ShrutiGkidney

[Anuja Java, MD (she/her) @anuja_java]

@LVRiella @kdjhaveri @ASNKidney @mgh_transplant @MGBKidneys Congratulations Leo!!

[American Society of Onconephrology @onconephsociety]

✨Session 4: AKI and Electrolyte Disturbances in Cancer and Novel Targeted Therapies

Cancer therapies continue to evolve, and so do the kidney complications we see with them.

🎙️ : @ZiolkowskiSusan

@onconeph @SheronLatcha @MaulinPatelDO

Register : https://t.co/aGTcge4zaS

[American Society of Onconephrology @onconephsociety]

Next off, we discuss Novel Radioligand Therapies and Nephrotoxicity

This session by @rc_oncneph will focus on these newer therapies and an important question for nephrologists: what do we need to know about their renal effects?

@onconeph @SheronLatcha @ShrutiGkidney

[NKF Nephrology Professionals @NKF_NephPros]

Explore Genetics in Kidney Care

The Genetics in Kidney Health Summit Recordings Showcase brings together established approaches, emerging research, and patient stories.

Watch on demand: https://t.co/VqvbNs3MYf

[American Society of Onconephrology @onconephsociety]

Update on Paraproteinemia and Kidney Pathologies: Monoclonal vs. Monotypic

This session by Lihong Bu will look at monoclonal vs. monotypic patterns and the renal pathologies we need to recognise.
@onconeph @SheronLatcha @rc_oncneph @ShrutiGkidney

[American Society of Onconephrology @onconephsociety]

Here’s the ASN Onconephrology Program at #KidneyWeek 2026 in Denver.

A full day covering new therapies, kidney complications of cancer treatment, transplant, pathology, immunotherapy, & case-based discussions.

Hope to see many of you there!
@onconeph @rc_oncneph @SheronLatcha

[aHUS Alliance Action @aHUSAllianceAct]

Keep growing your clinical knowledge after #aHUS24Sept. 📈Join the Society of Critical Care Medicine (@SCCM) this Friday for a webcast on accelerating diagnosis and improving outcomes for atypical HUS & #TMA. 🗓️25 Sept 2026⏰ 10:00 - 11:00 AM CT #aHUS #CriticalCare #MedEd

[aHUS Alliance Action @aHUSAllianceAct]

Keep growing your clinical knowledge after #aHUS24Sept. 📈Join the Society of Critical Care Medicine (@SCCM ) TODAY for a webcast on accelerating diagnosis and improving outcomes for atypical HUS & #TMA. 🗓️25 Sept 2026⏰ 10:00 - 11:00 AM CT #aHUS #CriticalCare #MedEd

[Anuja Java, MD (she/her) @anuja_java]

@aHUS24Sept We are in this together 😊🙏

[Anuja Java, MD (she/her) @anuja_java]

Today, on #aHUSAwarenessDay, we recognize the patients and families living with a rare and often unpredictable disease, and the community working alongside them!!
Every story adds to what we know. Every question still unanswered gives us a reason to keep going.

[aHUS Awareness Day @aHUS24Sept]

🔬 Diagnosing #aHUS remains a clinical challenge. Clinicians & researchers: Help others navigate complex aHUS diagnosis & care by sharing your work/insights with colleagues w/#aHUS24Sept. An expert review from @anuja_java on this complex #raredisease:
https://t.co/lk7lPAxTxC

[WashU Nephrology @WashUNephrology]

👏Check out recent publications @WashUNephrology by @Myasirbaloch, @anuja_java, @HumphreysLab, Chenjian Gu, and Yili Fang (Maggie Chen Lab).
https://t.co/JzW11wNEB8

[Fong Voon Ken @Ironken6]

ISN e-symposium today on genetic and clinical implications in aHUS management @anuja_java

@ISNkidneycare
@ISNeducation
#ThisIsISN
#ISNWebinar